Chloroquine, hydroxychloroquine and COVID-19

The media have featured the antimalarials chloroquine (CQ) and hydroxychloroquine (HCQ) to treat coronavirus (COVID-19). Political leaders have touted their use and recommended availability to the public. These anti-inflammatory agents have substantial human toxicity with a narrow therapeutic window...

Full description

Bibliographic Details
Main Authors: Erickson, T. B., Chai, P. R., Boyer, E. W.
Other Authors: Koch Institute for Integrative Cancer Research at MIT
Format: Article
Published: Informa UK Limited 2020
Online Access:https://hdl.handle.net/1721.1/125584